Uveal melanoma cells can be lysed by tyrosinase- and MAGE-3-specific CTL clones

被引：0
|
作者：
deWaardSiebinga, I
Visseren, MJW
Blom, DJR
Melief, CJM
Jager, MJ
机构：
[1] LEIDEN UNIV HOSP,DEPT OPHTHALMOL,LEIDEN,NETHERLANDS
[2] LEIDEN UNIV HOSP,DEPT IMMUNOHAEMATOL,2333 AA LEIDEN,NETHERLANDS
[3] LEIDEN UNIV HOSP,BLOOD BANK,2333 AA LEIDEN,NETHERLANDS
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1996年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：2878 / 2878
页数：1
相关论文
共 16 条
  • [1] CTL SPECIFIC FOR THE TYROSINASE AUTOANTIGEN CAN BE INDUCED FROM HEALTHY DONOR BLOOD TO LYSE MELANOMA-CELLS
    VISSEREN, MJW
    VANELSAS, A
    VANDERVOORT, EIH
    RESSING, ME
    KAST, WM
    SCHRIER, PI
    MELIEF, CJM
    JOURNAL OF IMMUNOLOGY, 1995, 154 (08): : 3991 - 3998
  • [2] Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients
    Valmori, D
    Lienard, D
    Waanders, G
    Rimoldi, D
    Cerottini, JC
    Romero, P
    CANCER RESEARCH, 1997, 57 (04) : 735 - 741
  • [3] Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients
    Maczek, C
    Berger, TG
    Schuler-Thurner, B
    Schultz, ES
    Hamann, A
    Dunbar, PR
    Cerundolo, V
    Steinkasserer, A
    Schuler, G
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (03) : 450 - 455
  • [4] Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.Al peptide
    Godelaine, D
    Carrasco, J
    Lucas, S
    Karanikas, V
    Schuler-Thurner, B
    Coulie, PG
    Schuler, G
    Boon, T
    Van Pel, A
    JOURNAL OF IMMUNOLOGY, 2003, 171 (09): : 4893 - 4897
  • [5] Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen:: Induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo
    Drexler, I
    Antunes, E
    Schmitz, M
    Wölfel, T
    Huber, C
    Erfle, V
    Rieber, P
    Theobald, M
    Sutter, G
    CANCER RESEARCH, 1999, 59 (19) : 4955 - 4963
  • [6] Diversity of the cytotoxic melanoma-specific immune response - Some CTL clones recognize autologous fresh tumor cells and not tumor cell lines
    Dufour, E
    Carcelain, G
    Gaudin, C
    Flament, C
    Avril, MF
    Faure, F
    JOURNAL OF IMMUNOLOGY, 1997, 158 (08): : 3787 - 3795
  • [7] Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells
    Vignard, V
    Lemercier, B
    Lim, A
    Pandolfino, MC
    Guilloux, Y
    Khammari, A
    Rabu, C
    Echasserieau, K
    Lang, F
    Gougeon, ML
    Dreno, B
    Jotereau, F
    Labarriere, N
    JOURNAL OF IMMUNOLOGY, 2005, 175 (07): : 4797 - 4805
  • [8] Vaccination with Mage-3 peptide-pulsed mature, monocyte-derived dendritic cells expands specific CTL and induces regression of some metastases in advanced stage IV melanoma
    Thurner, B
    Haendle, I
    Bender, A
    Dieckmann, D
    Keikavoussi, P
    Jonuleit, H
    Röder, C
    Maczek, C
    Schreiner, D
    Steinmann, A
    Balz, C
    von den Driesch, P
    Enk, A
    Kämpgen, E
    Schuler, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 431 - 431
  • [9] Modulation of proteasomal activity in vitro induces the generation of an HLA-A*0201 specific CTL-defined epitope derived from the melanoma-associated antigen MAGE-3
    Servis, C
    Lévy, F
    Cerottini, JC
    Romero, P
    Valmori, D
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 693 - 694
  • [10] LEUKEMIA-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) CLONES CAN BE GENERATED INVITRO BY STIMULATION OF HLA-GENOTYPICALLY IDENTICAL DONOR CELLS WITH RECIPIENT LEUKEMIC-CELLS
    FABER, LM
    WILLEMZE, R
    FALKENBURG, JHF
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 586 - 586
12